To read more, please visit:
http://www.abnnewswire.net/lnk/713SA081
About Anatara Lifesciences Ltd:
Anatara Lifesciences (ASX:ANR) is developing therapeutics for gastrointestinal diseases in production animals and humans. Its lead product Detach(R) is a natural plant based product that will help address global concerns around the overuse of antibiotics in production animals that is contributing to the rise of so-called “super bugs” that make infectious diseases harder to treat. The Anatara team has a strong track record in biological science as well as building and growing international biotech companies. Please see http://www.anataralifesciences.com for further background.
Source:
Anatara Lifesciences Ltd
Contact:
Investor inquiries: Dr Mel Bridges Chairman & CEO Anatara Lifesciences Phone: +61-413-051-600 Email: mbridges@anataralifesciences.com Media inquiries: Jane Lowe IR Department Phone: +61-411-117-774 Email: jane.lowe@irdepartment.com.au